FDA Warning Letter: Bioptimal International
CGMP/QSR/Medical Devices/Adulterated. Issued by FDA "OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality" on 2024-04-03.
FDA "OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality"